The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes in salivary adenoid cystic carcinoma.
 
Prarthana Dalal
No Relationships to Disclose
 
Sarah Dermody
No Relationships to Disclose
 
Collin Brummel
No Relationships to Disclose
 
Chad Brenner
No Relationships to Disclose
 
Keith Casper
No Relationships to Disclose
 
Steven B. Chinn
No Relationships to Disclose
 
Kelly M Malloy
No Relationships to Disclose
 
Michelle Lynn Mierzwa
Research Funding - Debiopharm Group
 
Molly Heft Neal
No Relationships to Disclose
 
Mark Prince
No Relationships to Disclose
 
Jennifer Lobo Shah
No Relationships to Disclose
 
Andrew Shuman
No Relationships to Disclose
 
Chaz Stucken
No Relationships to Disclose
 
Matthew Spector
Consulting or Advisory Role - Hologic; Merck
 
Francis P. Worden
Honoraria - Bristol-Myers Squibb; Eisai; EMD Serono; Exelixis; Merck Sharp & Dohme; Regeneron
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; eisai; Exelixis; Loxo; Merck; Regeneron
Research Funding - Bristol-Myers Squibb (Inst); CUE Biopharma (Inst); Eisai (Inst); Lilly (Inst); Loxo/Lilly (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bayer; Merck Sharp & Dohme
 
Paul Swiecicki
Honoraria - CDR-Life; Elevar Therapeutics; Elevar Therapeutics; Geovax Labs; Prelude Therapeutics; Remix Therapeutics; Seagen
Research Funding - Ascentage Pharma Group (Inst)